21st Century Oncology
21st Century Oncology
 

Background : Treatments : Radiation Therapy


BACKGROUND

Anatomy:

The esophagus is the medical term for the “food pipe.”  It connects the lower part of the throat (pharynx) with the stomach.  The esophagus begins in the lower neck and ends in the lower abdomen.  It lies in the chest just in front of the vertebral column and just behind the trachea (wind pipe).  The esophagus has a thin muscular wall and a mucosal lining.  In the upper three-fourths of the esophagus this epithelial lining comprises squamous cells. In the lower one-fourth the lining comprises columnar cells forming a glandular lining.

It is noteworthy that the esophagus has no outer coat or serosa.  Thus, there is relatively little barrier to prevent cancer cells from spreading into surrounding tissues.   Immediately adjacent to the esophagus are the other structures in the mediastinum, including the windpipe, lymph nodes, heart, and major blood vessels. 

Epidemiology:

Cancer of the esophagus represents about 1% of about all cancers in the United States. There are about 12,000 newly diagnosed cases per year in this country.  Cancer of the esophagus is more common in people who use tobacco products and in people who drink alcoholic beverages to excess. 

Another factor associated with esophageal cancer is esophageal reflux.  People who have severe esophageal reflux for many years can experience changes in their lower esophagus called “Barrett’s esophagus.”  A small percentage of people with Barrett’s esophagus will develop esophageal cancer.

Most cancers of the upper esophagus are squamous cell carcinoma.  Most cancers of the lower esophagus and gastroesophageal junction are adenocarcinoma.

STAGING:

Esophageal carcinoma occurs in the cells that line the inside of the esophagus.  Stage I disease means that the cancer is still confined to just this inner lining and has not started to spread into the muscular wall of the esophagus.  Stage II disease is disease growing into the muscular walls, but not into adjacent structures in the neck or chest.  Stage III disease means that the cancer has spread into adjacent tissue, such as the trachea or lymph nodes.  Stage IV disease has spread distantly to organs well away from the esophagus, such as the liver or lung tissue. 

TREATMENT OPTIONS:

Surgery:

Surgical resection for esophageal cancer is only practical in early stage disease (I or II).  Surgical resection involves major surgery.  In general, the entire esophagus is removed.  The stomach is then freed up from it abdominal location and brought up into the chest and connected with the lower throat. 

Radiation therapy:

Radiation therapy is used both as an alternative to surgery for early stage disease and as an adjunct to surgery in more advanced cases.  When radiation is used instead of surgery, relatively high doses are administered with the goal of eliminating the cancer, if possible.  When radiation is used as an adjunct to surgery, it can be given either before the major operation or after.  Radiation in these cases is generally confined to a more moderate dose. 

Chemotherapy:

Chemotherapy is often beneficial in providing results along with both surgery and radiation.  Drugs used include 5-Fluorouracil and Cisplatin. 

RADIATION THERAPY:

Typical course:

Some patients receive radiation therapy as the primary mode of treatment.  In this case, relatively high doses of radiation are given.  A typical course of treatment will consist of approximately 65-70 gray administered in approximately 40 individual treatments, five days a week over an eight-week period.  Radiation treatment usually is given from several different directions, front and back as well as sides.  The treatment is directed at the visible tumor as well as adjacent tissue where microscopic cancerous deposits may be hiding. 

In patients who receive radiation in conjunction with surgery, treatment can be given either before or after the major radiation.  Preoperative radiation therapy offers the advantage that the tumor may shrink and make the surgery easier.  Postoperative radiation therapy offers the advantage that the radiation fields can be constructed more carefully, based on the knowledge obtained by the surgeon.  Thus, the pluses and minuses of the two approaches have to be considered for each individual patient. 

Radiation given adjuvant to surgery is typically in a lower dose, 50 to 55 gray in 30 treatments over six weeks. 

Chemotherapy is frequently administered in conjunction with radiation therapy.  Studies have suggested a synergistic effect whereby chemotherapy enhances the effect of radiation on cancer cells without unduly sensitizing normal cells.  Chemotherapy has the additional advantage in that it may be able to eliminate small cancerous deposits located outside the radiation field.

Side-effects:

Side effects of radiation therapy for esophageal cancer include esophageal irritation and fatigue.  The esophageal irritation is a moderately severe difficulty which typically develops two to three weeks after the radiation initially begins.  There are medications that help control the sore throat, but it is not possible to prevent the it entirely.  Medications include soothing medicines such as Carafate and numbing medicines such as Ron’s Rum.  Another important class of medications that is helpful in these situations is antifungal treatment.  Patients receiving radiation therapy and chemotherapy for esophageal cancer are prone to develop a yeast infection (monilia).  Medicines such as Diflucan or Nystatin can be quite beneficial. 

Of course, patients with esophageal cancer are also at risk for inadequate nutrition.  Nutritional support can include counseling, as certain foods are much easier to swallow.  Nutritional support can also be administered mechanically by the placement of a rubber tube directly through the skin of the abdomen into the stomach (a PEG tube).  Please refer to the separate section in nutrition for more details regarding nutritional support.

A final side effect of radiation therapy is fatigue.  Patients receiving radiation often complain that they just don't have quite the energy that they did before the radiation started.  Some of this may be due to the underlying cancer itself.  The radiation, however, does tend to make people feel tired.  There is no cure for this symptom, but a program of extra naps and mild exercise can be helpful. 

 

 


Treatments | Cancer Info | Patient Info | About Us | Contact Us | RT School | Search | Home

( Legal Disclaimer, Medical Information Policy, Advertising Policy, Privacy Policy )

o




 http://www.21stCenturyOncology.com
Comments? Suggestions? Contact the Webmaster (Nicolas Chamero)
 © 2004 21st Century Oncology
 All rights reserved.

Last Modified: